Translation Services for IVD Manufacturers

IVD manufacturers typically need translation across IFUs, eIFUs, labels, packaging, intended purpose statements, specimen instructions, warnings, performance evaluation content, technical documentation, regulatory submissions, UDI/EUDAMED content, PMS and PMPF content, software UI, websites, marketing material, training content and Field Safety Notices. Many also need QMS documentation translation and SOP translation to support multilingual quality systems. AbroadLink provides IVDR translation services for IVD manufacturers through ISO-based workflows with qualified linguists, controlled terminology and risk-based workflow selection matched to department, document type and market.

Translation inside an IVD manufacturer is typically managed by IVD Regulatory Affairs Managers, QARA Managers, Documentation Managers and Product Managers, often working with software, technical, clinical, performance evaluation, marketing and distributor teams. Some manufacturers centralise translation through regulatory or documentation departments, while others run decentralised requests across product lines and markets. AbroadLink supports both models, helping manufacturers coordinate multilingual workflows with shared terminology, consistent risk-based workflow selection and traceable processes across IFUs, labelling, software, submissions and training material.

IVD localization services cover the adaptation of IVD content for specific markets, languages and user groups. They typically include software UI, eIFUs, websites, marketing material, training content and distributor communications, alongside regulated content such as IFUs, labelling, intended purpose and safety information. Localization preserves diagnostic clarity, regulatory wording and brand voice while respecting local market expectations. AbroadLink provides IVD localization services through qualified IVD linguists, controlled terminology, in-context review for software where appropriate and risk-based workflow selection matched to channel, audience and IVDR context.

Decentralised workflows can be reduced by centralising translation through a single specialised partner, sharing terminology and translation memories across departments, standardising risk-based workflow selection per document type and using audit-ready certificate access for traceability. AbroadLink supports IVD manufacturers with consolidated supplier relationships, centralised terminology, Translation Governance for QMS where structured supplier control is needed and CertLink for traceable certificates. Centralisation does not remove department ownership of content but reduces duplicated work, inconsistencies and supplier fragmentation across IVDR submissions, IFUs, software and labelling.

No. Lower-risk workflows do not lower the translation accuracy requirement. The objective remains accurate, complete and source-faithful translation for every IVD content type, including lower-risk internal drafts, administrative documents, repeated content, distributor support and non-critical marketing material. What changes between workflows is the depth of review, revision steps, terminology controls and validation activities applied to manage residual translation risk. A lower-risk workflow may be appropriate when content type, audience, department, IVD context, regulatory context, target markets and your internal controls support that decision, not because accuracy expectations are reduced.

AbroadLink reviews content type, IVD context, department ownership, regulatory exposure, audience, target markets and deadlines before proposing a workflow. IFUs, labelling, intended purpose, specimen instructions, safety wording, performance evaluation, software UI, regulatory submissions, PMS/PMPF and audit-facing records may justify ISO 17100 translation services with independent revision. Internal drafts, repeated content and lower-risk distributor support may justify a lighter workflow. AbroadLink supports workflow selection, but IVDR compliance, performance evaluation, software validation, notified body strategy and CE marking remain with your internal teams. See Linguistic Risk Assessment for more.

AI-assisted workflows can support IVD manufacturer translations in controlled scenarios, typically as a pre-translation step followed by qualified human review and validation. AbroadLink offers controlled AI workflows through aiHubLink, using client terminology, IVDR references and ISO-based processes. For IFUs, labelling, intended purpose, specimen instructions, safety warnings, performance evaluation, technical documentation, software UI, regulatory submissions, PMS/PMPF, patient-facing, user-facing and authority-facing content, AI should only be used with clear governance, qualified review and traceability. AI does not replace IVD-aware linguists, independent revision or internal regulatory, QARA, software and performance evaluation review.

No. IVDR translation services for IVD manufacturers, IVD localization services, IVD documentation translation, multilingual IVD compliance support, ISO 17100 translation services, AI-assisted workflows, certificates and risk-based workflow support do not guarantee IVDR compliance, notified body acceptance, competent authority acceptance, audit acceptance, product approval, CE marking, diagnostic performance, analytical performance, clinical performance, software validation, usability validation, safe use, correct use, market access or business outcomes. AbroadLink provides language services and translation workflow support. Decisions about IVDR compliance, performance evaluation, software validation and certification strategy remain with your regulatory, QARA, clinical, software and quality stakeholders.